HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Nozaki Selected Research

Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

11/2021Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.
1/2020HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature.
1/2019HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade.
5/2018Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation.
1/2017[Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)].
1/2017A CARASIL Patient from Americas with Novel Mutation and Atypical Features: Case Presentation and Literature Review.
1/2016Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL.
3/2013[Hereditary cerebral small-vessel disease].
1/2012[Consideration of the pathogenesis of CARASIL].
8/2011[Dementia: progress in diagnosis and treatment; Topics, V. Recent topics; 4. Detection of novel dementia-related genes; 2) Dysregulation of TGF-beta family signaling and hereditary cerebral small vessel disease: insight into molecular pathogenesis of CARASIL].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Nozaki Research Topics

Disease

13Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
11/2021 - 04/2009
6Cerebral Small Vessel Diseases
02/2020 - 04/2009
3Dementia (Dementias)
08/2011 - 11/2007
2CADASIL
08/2021 - 03/2013
2Alzheimer Disease (Alzheimer's Disease)
01/2008 - 11/2007
1Fibrosis (Cirrhosis)
01/2020
1Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy
12/2018
1Proteostasis Deficiencies
01/2016
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2016
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2016
1Hereditary Diffuse Leukoencephalopathy with Spheroids
01/2014
1Familial Cerebral Amyloid Angiopathy
03/2013
1Fabry Disease (Fabry's Disease)
03/2013
1Inborn Genetic Diseases (Disease, Hereditary)
03/2013
1Arteriosclerosis
06/2010
1Spondylosis
04/2009
1Alopecia (Baldness)
04/2009
1Disorders of Excessive Somnolence (Hypersomnia)
02/2009
1Craniocerebral Trauma (Head Injury)
02/2009
1Brain Neoplasms (Brain Tumor)
02/2009
1Brain Diseases (Brain Disorder)
02/2009
1Lewy Body Disease (Lewy Body Dementia)
11/2007
1Ataxia (Dyssynergia)
07/2007
1Thrombosis (Thrombus)
03/2006
1Venous Thrombosis (Deep-Vein Thrombosis)
03/2006
1Protein S Deficiency (Deficiency, Protein S)
03/2006
1Amnesia (Dissociative Amnesia)
03/2006

Drug/Important Bio-Agent (IBA)

6High-Temperature Requirement A Serine Peptidase 1IBA
11/2021 - 01/2012
5Peptide Hydrolases (Proteases)FDA Link
01/2017 - 06/2010
4Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2008
3Serine (L-Serine)FDA Link
01/2017 - 06/2010
3Fibronectins (Fibronectin)IBA
01/2012 - 06/2010
3Transforming Growth Factor beta (TGF-beta)IBA
08/2011 - 04/2009
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2008
2Retinaldehyde (Retinal)IBA
03/2013 - 07/2007
2Presenilin-1IBA
01/2008 - 11/2007
1candesartanIBA
11/2021
1Cysteine (L-Cysteine)FDA Link
08/2021
1Collagen Type IV (Type IV Collagen)IBA
02/2020
13' Untranslated Regions (3' UTR)IBA
02/2020
1Lamin Type B (Lamin B)IBA
12/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017
1Arginine (L-Arginine)FDA Link
01/2017
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2017
1DNA-Binding Proteins (DNA Binding Protein)IBA
01/2016
1Macrophage Colony-Stimulating FactorIBA
01/2014
1FurinIBA
01/2012
1Nonsense Codon (Nonsense Mutation)IBA
01/2012
1CollagenIBA
06/2010
1Versicans (Versican)IBA
06/2010
1Transforming Growth Factor beta1 (TGF beta 1)IBA
06/2010
1OrexinsIBA
02/2009
1SteroidsIBA
02/2009
1anti-aquaporin 4 autoantibodyIBA
02/2009
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2008
1Amyloid beta-PeptidesIBA
11/2007
1Flavin-Adenine Dinucleotide (FAD)IBA
11/2007
1Codon (Codons)IBA
11/2007
1alpha-SynucleinIBA
11/2007
1Threonine (L-Threonine)FDA Link
11/2007
1Warfarin (Coumadin)FDA LinkGeneric
03/2006
1Glycerol (Glycerine)FDA LinkGeneric
03/2006
1Heparin (Liquaemin)FDA LinkGeneric
03/2006

Therapy/Procedure

1Therapeutics
02/2009